Phyllodes tumors are rare breast tumors (0.3 to 1% of all breast tumors).
They are fibro-epithelial neoplasms that can be benign, borderline, or malignant.
The majority of phyllodes tumors are benign (60 to 75%).
The diagnostic criteria for malignant phyllodes tumours are well defined in the 2019 WHO classification.
Malignant phyllodes tumours are diagnosed when malignant heterologous elements are present (excluding well-differentiated liposarcoma) or when all of the five following features are present: marked nuclear pleomorphism, stromal overgrowth at 40× magnification (objective 4× and eyepiece 10× magnification), increased mitotic index (≥5 mitoses/mm
